LORRAINE CRESANTO: Open Payments
NPI 1487770962 · SALEM, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 116 payments from 14 companies in 2025. Trend: 2023 $1,415 · 2024 $1,558 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 71 | $939 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $236 |
| Aimmune Therapeutics, Inc. | 8 | $199 |
| Gilead Sciences, Inc. | 3 | $67 |
| Lilly USA, LLC | 3 | $64 |
| Madrigal Pharmaceuticals | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Janssen Biotech, Inc. | 2 | $40 |
| Ardelyx, Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $33 |
Products named: RINVOQ, ENTYVIO, MAVYRET, LINZESS, VOWST, VIBERZI, SKYRIZI, ZENPEP.
Industry payments across OH — which companies pay providers there.
